In a prospective study of 2,483 women with BRCA1 or BRCA2 mutations, no breast cancers were diagnosed in the women who underwent RRM during 3 years of prospective follow-up (Domchek et al., 2010). This evidence concerns the gene BRCA2 and breast carcinoma.